[多膜心脏缺陷纠正的长期结果]
V A Ivanov1, E P Evseev1, E V Ivanova1
1Petrovsky National Research Center of Surgery, Moscow, Russia.
Khirurgiia
|November 25, 2025
概括
多膜性心脏缺陷的手术纠正显著改善了长期生存和功能状态. 这种复杂的手术提供了有效的治疗,增强了血液动力学和患者的福祉,生存率为92.5%.
科学领域:
- 心血管外科心血管外科
- 医疗干预 医疗干预
- 患者的治疗结果.
背景情况:
- 多膜性心脏缺陷需要复杂的手术干预.
- 这种广泛的程序的长期结果对于患者管理至关重要.
- 评估手术后的功能状况和生存率至关重要.
研究的目的:
- 评估多膜心脏缺陷的手术纠正的长期结果.
- 评估门置换手术后的生存率和功能恢复.
- 在干预后分析并发症和血液动力学变化.
主要方法:
- 对51名接受更换两个或两个以上心脏门的患者的回顾性分析.
- 长期随访平均为19.5个月,评估生存率,NYHA功能类和并发症.
- 心声造影用于心脏重塑和血液动力学; 运动耐受性和气体交换.
主要成果:
- 长期精算生存率达到了92.5%,其中有一个致命的出血.
- 显著的健康状况有所改善:NYHA FC I的37.5%,FC II的54%.
- 95%没有出血并发症,没有血栓栓塞;改善了运动耐受性和峰值氧气消耗.
结论:
- 手术纠正是多膜心脏缺陷的唯一有效的长期治疗方法.
- 该程序显著改善了心内血液动力学,存活率和功能状态.
- 这种方法为患有复杂心脏病的患者提供了至关重要的解决方案.
相关概念视频
Mitral Regurgitation I: Introduction
392
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
392
Mitral Stenosis I: Introduction
420
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
420
Cardiomyopathy V: Interprofessional Care
316
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
316
Mitral Stenosis III: Medical Management
224
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
224
Mitral Regurgitation III: Medical Management
258
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
258
Cardiomyopathy II: Dilated Cardiomyopathy
449
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
449


